Biotech Reading List

What Happens After Your First Drug Approval?
Derek Lowe (In the Pipeline)

Change Is Unsettling … But Our Message Remains the Same
Alliance for a Stronger FDA

What You Need To Know About IMPROVE-IT
Larry Husten (CarbioBrief / Forbes)

Beg, Borrow, or Steal: Accessing Unaffordable Science Journals
Stewart Lyman (Xconomy)

Prostate Cancer Advertising: Lies and the Damn Lies (Part 1)
Benjamin Davies (Forbes)

Defining ‘Natural’ Is a Waste of F.D.A. Resources
Richard Williams (New York Times)